This activity is designed for hematologists/oncologists, nurses, and pharmacists.
Learning Objectives
After completing this activity, participants should be able to:
- Identify and stratify risk factors for VTE in cancer patients
- Discuss the epidemiology and prevalence of VTE in patients with cancer and elaborate on the contributions of various anti-cancer therapies to the development of VTE.
- Implement guideline-defined VTE prophylaxis and treatment in clinical practice.
No comments:
Post a Comment